{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T15:00:07Z","timestamp":1792335607802,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.clinthera.2010.03.016","type":"journal-article","created":{"date-parts":[[2010,4,30]],"date-time":"2010-04-30T08:57:25Z","timestamp":1272617845000},"page":"758-765","source":"Crossref","is-referenced-by-count":8,"title":["Bioequivalence evaluation of single doses of two tramadol formulations: A randomized, open-label, two-period"],"prefix":"10.1016","volume":"32","author":[{"given":"Marina de Freitas","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone Grigoleto","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice Kazue","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice Emiko Mori","family":"Koono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Helena","family":"dos Reis Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2010.03.016_bib1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/00003495-199346020-00008","article-title":"Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states","volume":"46","author":"Lee","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2010.03.016_bib2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00213-007-0847-3","article-title":"Modest opioid withdrawal suppression efficacy of oral tramadol in humans","volume":"194","author":"Lofwall","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.clinthera.2010.03.016_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.curtheres.2008.02.006","article-title":"Pharmacokinetics and postoperative analgesia of epidural tramadol: A prospective, pilot study","volume":"69","author":"Kubota","year":"2008","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.clinthera.2010.03.016_bib4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/00044011-200525070-00002","article-title":"Tramadol SR formulations: Pharmacokinetic comparison of a multiple-units dose (capsule) versus a single-unit dose (tablet)","volume":"25","author":"Cnota","year":"2005","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.clinthera.2010.03.016_bib5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1365-2125.2003.02013.x","article-title":"Pharmacokinetic evaluation of a new oral sustained release dosage form of tramadol","volume":"57","author":"Malonne","year":"2004","journal-title":"Br J Gin Pharmacol"},{"key":"10.1016\/j.clinthera.2010.03.016_bib6","first-page":"1278:1283","article-title":"Bioavailability of enteral tramadol formulations. 1st Communication: Capsules","volume":"36","author":"Lintz","year":"1986","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.clinthera.2010.03.016_bib7","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.clinthera.2006.12.007","article-title":"Pharmacokinetic and pharmacodynamic properties of tramadol IR and SR in elderly patients: A prospective, age-group-controlled study","volume":"28","author":"Likar","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2010.03.016_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.tvjl.2007.12.011","article-title":"Pharmacokinetic evaluation of tramadol and its major metabolites after single oral sustained tablet administration in the dog: A pilot study","volume":"180","author":"Giorgi","year":"2009","journal-title":"Vet J"},{"key":"10.1016\/j.clinthera.2010.03.016_bib9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/ajhp\/54.6.643","article-title":"Tramadol: A new centrally acting analgesic","volume":"54","author":"Lewis","year":"1997","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.clinthera.2010.03.016_bib10","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/00003088-200443130-00004","article-title":"Clinical pharmacology of tramadol","volume":"43","author":"Grond","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2010.03.016_bib11","first-page":"436","article-title":"Pharmacokinetics of tramadol and bioavailabihty of enteral tramadol formulations. 2nd Communication: Drops with ethanol","volume":"48","author":"Lintz","year":"1998","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.clinthera.2010.03.016_bib12","series-title":"Applied Biopharmaceuties and Pharmacokinetics","author":"Shargel","year":"1999"},{"key":"10.1016\/j.clinthera.2010.03.016_bib13","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.clinthera.2008.05.003","article-title":"Bioequivalence and pharmacokinetics of two zidovudine formulations in healthy Brazilian volunteers: An open-label, randomized, single-dose, two-way crossover study","volume":"30","author":"Dos Reis Serra","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2010.03.016_bib14","series-title":"http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?CFRPart=320&howFR=1","article-title":"US Dept of Health & Human Services, US Food and Drug Administration. CFR - Code of Federal Regulations. Title 21: Food and drugs. Subchapter D: Drugs for human use. Part 320: Bioavailability and bioequivalence requirements, 2009","year":"2010"},{"key":"10.1016\/j.clinthera.2010.03.016_bib15","series-title":"Dissolution, Bioavailabi & Bioequivalence","first-page":"554","author":"Abdou","year":"1989"},{"key":"10.1016\/j.clinthera.2010.03.016_bib16","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1023\/A:1013319408893","article-title":"Bioavailability and bioequivalence: An FDA regulatory overview","volume":"18","author":"Chen","year":"2001","journal-title":"Pharm Res"},{"key":"10.1016\/j.clinthera.2010.03.016_bib17","series-title":"Dicion\u00e1rio Terap\u00eautico Guanabara 2008\/2009","author":"Korolkovas","year":"2008"},{"key":"10.1016\/j.clinthera.2010.03.016_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2885.2007.00916.x","article-title":"Pharmacokinetics of tramadol and o-desmethyltramadol in goats after intravenous and oral admin istration","volume":"31","author":"de Sousa","year":"2008","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2010.03.016_bib19","series-title":"http:\/\/www.wma.net\/en\/60about\/70history\/01declarationHelsinki\/index.html","article-title":"World Medical Association. Declaration of Helsinki: Recommendations guiding physicians in bio medical research involving human subjects","year":"2010"},{"key":"10.1016\/j.clinthera.2010.03.016_bib20","series-title":"http:\/\/www.ema.europa.eu\/pdfs\/human\/ich\/013595en.pdf","article-title":"European Agency for the Evaluation of Medicinal Products (EMEA), International Conference on Har monisation, World Health Organization (WHO). Guideline for Good Clinical Practice. ICH Topic E 6 (R1)","year":"2010"},{"key":"10.1016\/j.clinthera.2010.03.016_bib21","series-title":"http:\/\/e-legis.anvisa.gov.br\/leisref\/public\/showAct.php?id=21746&word=","year":"2010"},{"key":"10.1016\/j.clinthera.2010.03.016_bib22","series-title":"http:\/\/e-legis.anvisa.gov.br\/leisref\/public\/showAct.php?id=15132&word=","year":"2010"},{"key":"10.1016\/j.clinthera.2010.03.016_bib23","series-title":"http:\/\/www.fda.gov\/downloads\/Drugs\/DevelopmentApprovalProcess\/HowDrugsareDevelopedandApproved\/ApprovalApplications\/AbbreviatedNewDrugsApplicationANDAGenerics\/UCM154838.pdf","year":"2010"},{"key":"10.1016\/j.clinthera.2010.03.016_bib24","series-title":"Handbook of Basic Pharmacokinetics\u2014Including Clinical Applications","author":"Ritschel","year":"2004"},{"key":"10.1016\/j.clinthera.2010.03.016_bib25","series-title":"Design and Analysis of Bioavailability and Bioequiualence Studies","first-page":"79","article-title":"Statistical methods for average bioavailability","author":"Chow","year":"2000"},{"key":"10.1016\/j.clinthera.2010.03.016_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1570-0232(02)00065-X","article-title":"Method development and validation of a high-performance liquid chromatographic method for tramadol in human plasma using liquid-liquid extraction","volume":"772","author":"Gan","year":"2002","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.clinthera.2010.03.016_bib27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0378-4347(98)00514-3","article-title":"High performance liquid chromatographic method for determination of tramadol in human plasma","volume":"723","author":"Yeh","year":"1999","journal-title":"J Chromatogr B Biomed Sci Appl"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810001074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810001074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T09:18:59Z","timestamp":1711444739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291810001074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0149291810001074"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2010.03.016","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}